Literature DB >> 27213350

Retraction: Zihan Xu, et al. Tanshinone IIA Pretreatment Renders Free Flaps against Hypoxic Injury through Activating Wnt Signaling and Upregulating Stem Cell-Related Biomarkers. Int. J. Mol. Sci. 2014, 15, 18117-18130.

.   

Abstract

We have been made aware that text, figures and experimental data reported in the title paper [1] are duplicated in another publication by Zihan Xu et al. [2].[...].

Entities:  

Year:  2016        PMID: 27213350      PMCID: PMC4881587          DOI: 10.3390/ijms17050768

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


We have been made aware that text, figures and experimental data reported in the title paper [1] are duplicated in another publication by Zihan Xu et al. [2]. At the time of submission, [1] had already been submitted to another journal and was under active consideration. The International Journal of Molecular Sciences is a member of the Committee on Publication Ethics and takes the responsibility to enforce strict ethical policies and standards very seriously. To ensure the addition of only high quality scientific works to the field of scholarly publication, paper [1] is retracted and shall be marked accordingly. We apologize to our readership that this went undetected until now.
  2 in total

1.  Tanshinone IIA pretreatment protects free flaps against hypoxic injury by upregulating stem cell-related biomarkers in epithelial skin cells.

Authors:  Zihan Xu; Lijun Wu; Yaowen Sun; Yadong Guo; Gaoping Qin; Shengzhi Mu; Ronghui Fan; Benfeng Wang; Wenjie Gao; Zhenxin Zhang
Journal:  BMC Complement Altern Med       Date:  2014-09-04       Impact factor: 3.659

2.  Tanshinone IIA pretreatment renders free flaps against hypoxic injury through activating Wnt signaling and upregulating stem cell-related biomarkers.

Authors:  Zihan Xu; Zhenxin Zhang; Lijun Wu; Yaowen Sun; Yadong Guo; Gaoping Qin; Shengzhi Mu; Ronghui Fan; Benfeng Wang; Wenjie Gao
Journal:  Int J Mol Sci       Date:  2014-10-09       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.